Shareholders have approved a massive transaction that could create a conglomerate in the marijuana industry.
On Wednesday (June 19), investors of New York-based multi-state operator (MSO) Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF) and Canadian producer Canopy Growth (NYSE:CGC,TSX:WEED) okayed a deal between the two firms.
Canopy Growth spent US$300 million to get the option to acquire Acreage when marijuana becomes federally legal in the US. In total, the transaction is estimated to be worth US$3.4 billion.
Shareholders from both firms overwhelmingly voted in support of the deal, with 95 percent of Acreage investors and 99.05 percent of Canopy Growth holders agreeing to the outlined terms of the acquisition.
“Alongside our international market strategies and US Hemp strategy, we believe the acquisition of Acreage will be a key step in bolstering our position as a truly global company,” Bruce Linton, co-CEO of Canopy Growth, said in a press release.
Kevin Murphy, founder and CEO of Acreage, thanked shareholders for approving the deal.
Shares of the two companies enjoyed a slight jump in Wednesday’s trading session.
Shares of Canopy Growth in New York and Toronto finished the day respectively at US$42.77 and C$56.85, representing price increases of 1.74 percent and 0.87 percent, while shares of Acreage increased by 3.16 percent for a closing price of US$19.60.
Now, with voter support, shareholders will wait to see just how long it will be until Canopy Growth can complete its acquisition.
Acreage management has indicated that it will race to expand its portfolio so that once Canopy Growth can swoop in and complete the transaction, the Canadian firm will obtain a larger MSO.
After the original announcement of the deal, Alan Brochstein, cannabis analyst with 420 Investor, highlighted that the MSO will now be capable of hitting the market and finding quality partners to expand its own business.
As part of the deal, Acreage will also gain use of the brands and intellectual property held by Canopy Growth.
“We expect that potential acquisition candidates will have more confidence in the equity of Acreage given that it will be tethered to Canopy,” he said.
Steve West, vice president of investor relations at Acreage, previously told the Investing News Network that that is the plan for the MSO now: to go out and continue merger and acquisition activity.
Don’t forget to follow us @INN_Cannabis for real-time updates!
Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.